Pharma & Biotech
The 2018 Drug Review Annual Report released
On 01.07.2019, the 2018 Drug Review Annual Report was released. Of the grand sum of 9,796 registration applications reviewed and approved in 2018, 7,988 were subject to technical review and 1,808 to direct administrative approval.
March 11, 2026
Overseas New Drugs Urgently Needed
On 25.06.2019, the NMPA announced the requirements for overseas new drugs, which are urgently needed. The guidelines serve to speed up the drug approval.
March 11, 2026
Vaccine Administration Law
On June 29, 2019, the NMPA minister Jiao Hong attended a press briefing on the implementation a strict administration law over vaccines.
March 30, 2022
Approval of Clinically Urgent New Drugs
On October 30, 2018, the NMPA issued guidelines for the approval of clinically urgent new drugs covering the procedure, requirements, etc.
March 11, 2026
Get in Touch with our Certifications team
And discover how we can support you in getting your products certified for China.